DOAC renal review — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Query anticoagulant dose and suitability in light of renal function
Dabigatran is substantially renally cleared, so renal impairment can increase bleeding risk. Acute changes in renal function should prompt review of dose and suitability. The other options either delay appropriate care, use an unsuitable medicine, or miss the main safety issue.
Reference: BNF